Eline S Zwart1,2,3, Thomas van Ee2,3,4, Deesje Doppenberg1,5

  • 1Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

概括

在胰腺癌患者中,新辅助的FOLFIRINOX治疗促进了亲炎性免疫反应,与凝胺加放射治疗或前期手术不同. 瘤组织通常会在治疗后表现出一种更具免疫抑制性的微环境.